I agree that this site is using cookies. You can find further informations here.
X
Powderly, John D.
99  results:
Search for persons X
?
1

First-in-human Phase I Trial of TPST-1120, an Inhibitor of ..:

Yarchoan, Mark ; Powderly, John D. ; Bastos, Bruno R....
Cancer Research Communications.  4 (2024)  4 - p. 1100-1110 , 2024
Link: https://doi.org/10.1158/..
 
?
2

Brief Report: Safety and Antitumor Activity of Durvalumab P..:

Garon, Edward B. ; Spira, Alexander I. ; Goldberg, Sarah B....
Journal of Thoracic Oncology.  18 (2023)  8 - p. 1094-1102 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Exploring the safety, effect on the tumor microenvironment,..:

Naing, Aung ; Powderly, John D ; Nemunaitis, John J...
Journal for ImmunoTherapy of Cancer.  10 (2022)  3 - p. e004223 , 2022
Link: https://doi.org/10.1136/..
 
?
4

Phase 1/2 study of epacadostat in combination with durvalum..:

Naing, Aung ; Algazi, Alain P. ; Falchook, Gerald S....
Cancer.  129 (2022)  1 - p. 71-81 , 2022
Link: https://doi.org/10.1002/..
 
?
5

Epacadostat Plus Pembrolizumab and Chemotherapy for Advance..:

Powderly, John D ; Klempner, Samuel J ; Naing, Aung...
The Oncologist.  27 (2022)  11 - p. 905-e848 , 2022
Link: https://doi.org/10.1093/..
 
?
6

Final overall survival and safety update for durvalumab in ..:

Garassino, Marina Chiara ; Cho, Byoung-Chul ; Kim, Joo-Hang...
Lung Cancer.  147 (2020)  - p. 137-142 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Model Informed Dosing Regimen and Phase I Results of the An..:

Powderly, John ; Spira, Alexander ; Kondo, Shunsuke...
Clinical and Translational Science.  14 (2020)  1 - p. 277-287 , 2020
Link: https://doi.org/10.1111/..
 
?
8

Long-term survival follow-up of atezolizumab in combination..:

Liu, Stephen V. ; Camidge, D. Ross ; Gettinger, Scott N....
European Journal of Cancer.  101 (2018)  - p. 114-122 , 2018
Link: https://doi.org/10.1016/..
 
?
9

PL04a.03: Durvalumab in ≥3rd-Line Locally Advanced or Metas..:

Garassino, Marina ; Vansteenkiste, Johan ; Kim, Joo-Hang...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S10-S11 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Evaluation of the effect of necitumumab on the corrected QT..:

Smith, David C. ; Powderly, John ; Lee, James J....
Cancer Chemotherapy and Pharmacology.  78 (2016)  2 - p. 271-280 , 2016
Link: https://doi.org/10.1007/..
 
?
11

Predictive correlates of response to the anti-PD-L1 antibod..:

Herbst, Roy S. ; Soria, Jean-Charles ; Kowanetz, Marcin...
Nature.  515 (2014)  7528 - p. 563-567 , 2014
Link: https://doi.org/10.1038/..
 
?
12

Differential drug responses of circulating tumor cells with..:

Hughes, Andrew D. ; Marshall, Jocelyn R. ; Keller, Eric...
Cancer Letters.  352 (2014)  1 - p. 28-35 , 2014
Link: https://doi.org/10.1016/..
 
?
13

Intratumoral characteristics of tumor and immune cells at b..:

Kohrt, Holbrook ; Kowanetz, Marcin ; Gettinger, Scott...
Journal for ImmunoTherapy of Cancer.  1 (2013)  S1 - p. , 2013
Link: https://doi.org/10.1186/..
 
?
14

Rapid Isolation of Viable Circulating Tumor Cells from Pati.. 

JoVE : Bioengineering
Hughes, Andrew D. ; Mattison, Jeff ; Powderly, John D... , 2012
Link: https://www.jove.com/t/4..
 
?
15

Microtube Device for Selectin-Mediated Capture of Viable Ci..:

King, Michael R ; Greene, Bryan T ; Powderly, John D...
Clinical Chemistry.  58 (2012)  5 - p. 846-853 , 2012
Link: https://doi.org/10.1373/..
 
1-15